Stephen J. McAndrew, SVP Business Strat. & Development at Oncobiologics, Inc. (ONS), sold 15,705 shares at $1.13 ($18K) on 2017-12-22, disclosed to the SEC on 2017-12-26.
Scheduled sale ($18k) by SVP Business Strat. & Development.
Something here stands out, but not much.